Q2 FY2024 net sales rose 6.9% year-over-year, but operating income and net income declined due to growth investments, especially in China. Full-year guidance and dividend forecasts remain unchanged, with strong product launches and continued global expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.